Диссертация (1139667), страница 29
Текст из файла (страница 29)
Intracranial hemorrhage mortality in atrial fibrillation patientstreated with dabigatran or warfarin. Stroke. 2014;45(8):2286–2291.94.Alvarez-Sabin J., Ortega G., Jacas C. et al. Citicoline treatment preventsneurocognitive decline after a first ischemic stroke (Poster 743) // Cerebrovasc. Dis.2010; 29 (Suppl 2): 268.21595.Alvarez-Sabin J., Roman G.С. Citicoline in vascular cognitive impairment andvascular dementia after stroke // Stroke. 2011; 42: S40-S43.96.Amarenco P, Benavente O, Goldstein LB, et al; Stroke Preven¬tion byAggressive Reduction in Cholesterol Levels Investiga¬tors. Results of the StrokePrevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by strokesubtypes.
Stroke. 2009;40(4):1405–1409.97.Amarenco P, Davis S, Jones EF, et al. Clopidogrel plus aspirin versus warfarinin patients with stroke and aortic arch plaques. Stroke. 2014; 45(5):1248–1257.98.Andersen G, Vestergaard K, Riis J, Lauritzen L. Incidence of post-strokedepression during the first year in a large unselected stroke population determined usinga valid standardized rating scale. Acta Psychiatr Scand. 2007;90(3):190–195.99.Ansell JE, Bakhru SH, Laulicht BE, et al. Use of PER977 to reverse theanticoagulant effect of edoxaban.
N Engl J Med. 2014;371(22): 2141–2142.100. Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor fordementia and cognitive decline: a meta-analysis of prospective studies. Am JEpidemiol. 2007; 166:367–378.101. Antithrombotic Trialists’ (ATT) Collaboration, Baigent C, Blackwell L, et al.Aspirin in the primary and secondary prevention of vascular disease: collaborativemeta-analysis of individual participant data from randomised trials. Lancet.2009;373(9678):1849–1860.102. Arboix A, Martí-Vilalta JL.
Lacunar stroke. Expert Rev Neurother.2009;9(2):179–196.103. Avecilla ST, Ferrell C, Chandler WL, Reyes M. Plasma-diluted thrombin timeto measure dabigatran concentrations during dabigatran etexilate therapy. Am J ClinPathol. 2012;137(4):572–574.104. Ay H, Benner T, Arsava EM, et al.
A computerized algorithm for etiologicclassification of ischemic stroke: the Causative Classification of Stroke System. Stroke.2007;38(11):2979–2984.216105. Bejot Y., Aboa-Eboule C., Durier Jerome. et al. Prevalence of early dementiaafter first-ever stroke: a 24-year population-based study // Stroke. 2011; 42: 607-612.106. Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, et al.Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl JMed. 2012; 367: 817–825.107. Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA.Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
N Engl JMed. 2012; 367:817-825.108. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, HennericiMG, Mattle HP, Rothwell PM, de Cordoue A, Fratacci MD. Terutroban versus aspirinin patients with cerebral ischaemic events (PERFORM): A randomised, double-blind,parallel-group trial. Lancet. 2011; 377:2013-2022.109. Brayne C., Ince P.G., Keage H.A.
EClipSE Collaborative Members. Education,the brain and dementia: Neuroprotection or compensation? // Brain. 2010 Aug; 133:2210.110. Brennan JM, Edwards FH, Zhao Y, et al; DEcIDE AVR (Developing Evidenceto Inform Decisions about Effectiveness–Aortic Valve Replacement) Research Team.Long-term safety and effectiveness of mechanical versus biologic aortic valveprostheses in older patients: results from the Society of Thoracic Surgeons AdultCardiac Surgery National Database.
Circulation. 2013;127(16):1647–1655.111. Brott TG, Hobson RW 2nd, Howard G, et al; CREST Investigators. Stentingversus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med.2010;363(1):11–23.112. BrottTG.CarotidRevascularizationandMedicalManagementforAsymptomatic Carotid Stenosis Trial (CREST-2). In: ClinicalTrials.gov [website on theInternet].
Bethseda, MD: US National Library of Medi-cine; 2014 [updated May 27,2015].Availablefrom:https://clinicaltrials.gov/ct2/show/NCT02089217.identifier: NCT02089217. Accessed April 14, 2015.NLM217113. Camm AJ, Lip GY, De Caterina R, et al; ESC Committee for PracticeGuidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines forthe management of atrial fibrillation: an update of the 2010 ESC Guidelines for themanagement of atrial fibrillation – developed with the special contribution of theEuropean Heart Rhythm Association.
Europace. 2012;14(10):1385–1413.114. Campbell S, Moffatt R, Stamford B (2008) Smoking and smoking cessation: therelationship between cardiovascular disease and lipoprotein metabolism—A review.Atherosclerosis 20(2): 225–35.115. Carod-Artal F, Ferreira Coral L, Trizotto D, Menezes Moreira C. Poststrokedepression: prevalence and determinants in Brazilian stroke patients. Cerebrovasc Dis.2009;28(2):157–165.116. Carod-Artal F.
Are mood disorders a stroke risk factor? Stroke. 2007; 38(1):1–3.117. Carroll JD, Saver JL, Thaler DE, et al; RESPECT Investigators. Closure ofpatent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med.2013;368(12):1092–1100.118. Cheng HL, 443. Lin CJ, Soong BW, Wang PN, Chang FC, Wu YT, Chou KH,Lin CP, Tu PC, Lee IH. Impairments in cognitive function and brain connectivity insevere asymptomatic carotid stenosis.
Stroke. 2012 Oct;43(10):2567-73119. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee andInvestigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl JMed. 2009;361(12):1139–1151.120. Cumming T.B., Marshall R.S., Lazar R.M. Stroke, cognitive deficits andrehabilitation still an incomplete picture/ Int J Stroke. 2013 Jan; 8(1):38-45.121. Damush TM, Ofner PS, Yu Z, Plue L, Nicholas G, Williams LS (2011) AbstractTP415: Implementation of a secondary stroke prevention program Transl Behav Med1(4): 561–572.122.
Demaerschalk B.M., Wingerchuk D.M. Treatment of vascular dementia andvascular cognitive impairment // Neurologist. 2007; Vol. 13: 37-41.218123. Deplanque D, Lavallee PC, Labreuche J, et al; Lacunar-BICHAT Investigators.Cerebral and extracerebral vasoreactivity in symp¬tomatic lacunar stroke patients: acase-control study. Int J Stroke. 2013;8(6):413–421.124. Derdeyn CP, Chimowitz MI, Lynn MJ, et al; Stenting and Aggressive MedicalManagement for Preventing Recurrent Stroke in Intracranial Stenosis TrialInvestigators.
Aggressive medical treatment with or without stenting in high-riskpatients with intracranial artery stenosis (SAMMPRIS): the final results of a randomisedtrial. Lancet. 2014; 383(9914):333–341.125. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S; Patent ForamenOvale in Cryptogenic Stroke Study Investigators. Aortic arch plaques and risk ofrecurrent stroke and death. Circulation.
2009; 119(17):2376–2382.126. DiabetesControlandComplicationsTrial/EpidemiologyofDiabetesInterventions and Complications (DCCT/EDIC) Research Group, Nathan DM, ZinmanB, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration:the diabetes control and complications trial/epidemiology of diabetes interventions andcomplications and Pittsburgh epidemiology of diabetes complications experience(1983–2005). Arch Intern Med. 2009;169(14):1307–1316.127. Dixon A. Motivation and Confidence: what does it take to change behaviour?London, The Kings Fund.
Accessed 06 December 2014.128. Dong Y., Sharma V.K., Chan B.P. et al. The Montreal Cognitive Assessment(MoCA) is superior to the Mini-Mental State Examination (MMSE) for detection ofvascular cognitive impairment after acute stroke. J Neurosci 2010;299(1–2):15–8.129. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment:South london stroke register 1995-2010. Stroke. 2013 Jan;44(1):138-45130. Dubois B., Feldman H.H., Jacova C.
et al. Research criteria for the diagnosis ofAlzheimer’s disease: revising of the NINCDS-ADRDRA criteria. Lancet Neurol2007;6(8):734–46.219131. Eames S, Hoffmann T, Worrall L, Read S, Wong A (2013) Randomisedcontrolled trial of an education and support package for stroke patients and their carers.BMJ Open 3: 2013. -80(3): 315-22.132. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-ProtectedAngioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomaticstenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol.2008;7(10):893–902.133.
Edwards J.D., Jacova C., Sepehry A.A., Pratt B., Benavente O.R. A quantitativesystematic review of domain-specific cognitive impairment in lacunar stroke//Neurology. 2013; Jan; 15; 80(3):315-22.134. Eikelboom JW, Connolly SJ, Brueckmann M, et al; RE-ALIGN Investigators.Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med.2013;369(13):1206–1214.135.
Estruch R, Ros E, Martínez-González MA. Mediterranean diet for primaryprevention of cardiovascular disease. N Engl J Med. 2013; 369(7):676–677.136. European Stroke Organisation (ESO) Executive Committee; ESO WritingCommittee. Guidelines for management of ischaemic stroke and transient ischaemicattack // Cerebrovasc Dis. – 2008; 25:457–507.137. Faulkner J, Lambrick D, Woolley B, McGonigal G, Stoner L, Wong L (2013b)Effects of Early Exercise Engagement on Vascular Risk in Patients with TransientIschemic Attack and Nondisabling Stroke. J Stroke Cerebrovasc Dis 22(8): 388– 396.138. Faulkner J, Lambrick D, Woolley B, Stoner L, Wong L, McGonigal G (2013a)Health-enhancing physical activity programme (HEPAP) for transient ischaemic attackand non-disabling stroke: recruitment and compliance.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
